1. Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial
   Chengtao Zhang et al, 2023, Frontiers in Oncology CrossRef
2. Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia
   Wenxiu Lv et al, 2023, Frontiers in Pediatrics CrossRef